Laboratory methods and quality assurance in the Cardiovascular Health Study.

PubWeight™: 7.73‹?› | Rank: Top 0.1%

🔗 View Article (PMID 7874780)

Published in Clin Chem on February 01, 1995

Authors

M Cushman1, E S Cornell, P R Howard, E G Bovill, R P Tracy

Author Affiliations

1: Department of Pathology, University of Vermont College of Medicine, Burlington 05401.

Associated clinical trials:

EXercise Training for the Prevention of Cancer Thrombosis (EXPECT) Pilot Trial (EXPECT) | NCT01853202

Articles citing this

(truncated to the top 100)

Association of weight status with mortality in adults with incident diabetes. JAMA (2012) 7.49

Dietary patterns are associated with biochemical markers of inflammation and endothelial activation in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr (2006) 3.93

Fish intake and risk of incident atrial fibrillation. Circulation (2004) 2.82

Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol (2009) 2.79

Higher circulating adiponectin levels are associated with increased risk of atrial fibrillation in older adults. Heart (2015) 2.67

Adiponectin and risk of coronary heart disease in older men and women. J Clin Endocrinol Metab (2008) 2.65

Circulating omega-6 polyunsaturated fatty acids and total and cause-specific mortality: the Cardiovascular Health Study. Circulation (2014) 2.63

Bioindicators in the MIDUS national study: protocol, measures, sample, and comparative context. J Aging Health (2010) 2.63

Vitamin D, parathyroid hormone, and cardiovascular events among older adults. J Am Coll Cardiol (2011) 2.56

The association between physical activity and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol (2008) 2.43

Population structure, admixture, and aging-related phenotypes in African American adults: the Cardiovascular Health Study. Am J Hum Genet (2005) 2.41

Association of gene variants with incident myocardial infarction in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol (2007) 2.36

Leukocyte telomere length and mortality in the Cardiovascular Health Study. J Gerontol A Biol Sci Med Sci (2011) 2.19

Coagulation factors IX through XIII and the risk of future venous thrombosis: the Longitudinal Investigation of Thromboembolism Etiology. Blood (2009) 2.07

N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study. Circulation (2009) 1.99

Racial differences in risks for first cardiovascular events and noncardiovascular death: the Atherosclerosis Risk in Communities study, the Cardiovascular Health Study, and the Multi-Ethnic Study of Atherosclerosis. Circulation (2012) 1.99

Association between metabolic syndrome and sleep-disordered breathing in adolescents. Am J Respir Crit Care Med (2007) 1.98

Relationship of abnormal heart rate turbulence and elevated CRP to cardiac mortality in low, intermediate, and high-risk older adults. J Cardiovasc Electrophysiol (2010) 1.98

Chronic kidney disease increases risk for venous thromboembolism. J Am Soc Nephrol (2007) 1.80

Inflammation and the incidence of type 2 diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care (2010) 1.80

The risk of infection-related hospitalization with decreased kidney function. Am J Kidney Dis (2011) 1.79

Plasma omega-3 fatty acids and incident diabetes in older adults. Am J Clin Nutr (2011) 1.79

Persistent subclinical hypothyroidism and cardiovascular risk in the elderly: the cardiovascular health study. J Clin Endocrinol Metab (2012) 1.75

Body mass index and mortality in nonsmoking older adults: the Cardiovascular Health Study. Am J Public Health (1998) 1.73

Associations between markers of subclinical atherosclerosis and dietary patterns derived by principal components analysis and reduced rank regression in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr (2007) 1.72

Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study. Neurology (2008) 1.71

Meta-analysis of gene-environment interaction: joint estimation of SNP and SNP × environment regression coefficients. Genet Epidemiol (2011) 1.71

Chronic kidney disease and the risk of end-stage renal disease versus death. J Gen Intern Med (2010) 1.66

Coronary artery calcium, carotid artery wall thickness, and cardiovascular disease outcomes in adults 70 to 99 years old. Am J Cardiol (2008) 1.63

Dietary patterns and incident cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis. Am J Clin Nutr (2009) 1.62

Sex hormones are associated with right ventricular structure and function: The MESA-right ventricle study. Am J Respir Crit Care Med (2010) 1.57

Association of plasma phospholipid long-chain ω-3 fatty acids with incident atrial fibrillation in older adults: the cardiovascular health study. Circulation (2012) 1.54

Cardiomyocyte injury assessed by a highly sensitive troponin assay and sudden cardiac death in the community: the Cardiovascular Health Study. J Am Coll Cardiol (2013) 1.53

Total and cause-specific mortality in the cardiovascular health study. J Gerontol A Biol Sci Med Sci (2009) 1.53

N-terminal pro-B-type natriuretic peptide is associated with sudden cardiac death risk: the Cardiovascular Health Study. Heart Rhythm (2010) 1.48

Long-term function in an older cohort--the cardiovascular health study all stars study. J Am Geriatr Soc (2009) 1.46

Plasma free fatty acids and risk of stroke in the Cardiovascular Health Study. Int J Stroke (2014) 1.45

Associations of inflammatory markers with coronary artery calcification: results from the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis (2009) 1.44

Impact of freeze-thaw cycles and storage time on plasma samples used in mass spectrometry based biomarker discovery projects. Cancer Inform (2005) 1.43

Plasma phospholipid long-chain ω-3 fatty acids and total and cause-specific mortality in older adults: a cohort study. Ann Intern Med (2013) 1.43

Inflammatory markers and longitudinal lung function decline in the elderly. Am J Epidemiol (2008) 1.42

Physical activity and rapid decline in kidney function among older adults. Arch Intern Med (2009) 1.40

Cardiac microinjury measured by troponin T predicts collagen metabolism in adults aged >=65 years with heart failure. Circ Heart Fail (2012) 1.39

Association between hyperuricemia and incident heart failure among older adults: a propensity-matched study. Int J Cardiol (2009) 1.38

Obesity and change in estimated GFR among older adults. Am J Kidney Dis (2009) 1.37

Fish consumption and stroke risk in elderly individuals: the cardiovascular health study. Arch Intern Med (2005) 1.35

Associations of pentraxin 3 with cardiovascular disease and all-cause death: the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol (2009) 1.33

Vitamin D, parathyroid hormone, and sudden cardiac death: results from the Cardiovascular Health Study. Hypertension (2011) 1.29

trans-Palmitoleic acid, other dairy fat biomarkers, and incident diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr (2013) 1.28

Associations of factor VIIIc, D-dimer, and plasmin-antiplasmin with incident cardiovascular disease and all-cause mortality. Am J Hematol (2009) 1.26

Measures of adiposity and future risk of ischemic stroke and coronary heart disease in older men and women. Am J Epidemiol (2010) 1.26

Simple biologically informed inflammatory index of two serum cytokines predicts 10 year all-cause mortality in older adults. J Gerontol A Biol Sci Med Sci (2013) 1.25

Diabetes and coronary heart disease as risk factors for mortality in older adults. Am J Med (2010) 1.24

Empirical evidence for "syndrome Z": a hierarchical 5-factor model of the metabolic syndrome incorporating sleep disturbance measures. Sleep (2009) 1.24

Insulin-like growth factor-(IGF)-axis, inflammation, and glucose intolerance among older adults. Growth Horm IGF Res (2007) 1.23

Left ventricular hypertrophy in mild and moderate reduction in kidney function determined using cardiac magnetic resonance imaging and cystatin C: the multi-ethnic study of atherosclerosis (MESA). Am J Kidney Dis (2008) 1.22

Food sources of individual plasma phospholipid trans fatty acid isomers: the Cardiovascular Health Study. Am J Clin Nutr (2010) 1.22

Serum 25-hydroxyvitamin D and change in estimated glomerular filtration rate. Clin J Am Soc Nephrol (2011) 1.20

Associations of dietary long-chain n-3 polyunsaturated fatty acids and fish with biomarkers of inflammation and endothelial activation (from the Multi-Ethnic Study of Atherosclerosis [MESA]). Am J Cardiol (2009) 1.20

Association of fetuin-a with incident diabetes mellitus in community-living older adults: the cardiovascular health study. Circulation (2012) 1.18

IL-6 gene variation is associated with IL-6 and C-reactive protein levels but not cardiovascular outcomes in the Cardiovascular Health Study. Hum Genet (2007) 1.18

Echocardiographic diastolic parameters and risk of atrial fibrillation: the Cardiovascular Health Study. Eur Heart J (2011) 1.17

Inflammatory biomarkers and decline in kidney function in the elderly: the Cardiovascular Health Study. Nephrol Dial Transplant (2009) 1.17

Cholesteryl ester transfer protein genetic polymorphisms, HDL cholesterol, and subclinical cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis (2008) 1.16

Higher serum testosterone concentration in older women is associated with insulin resistance, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab (2009) 1.16

Kidney function and prevalent and incident frailty. Clin J Am Soc Nephrol (2013) 1.16

Novel measures of heart rate variability predict cardiovascular mortality in older adults independent of traditional cardiovascular risk factors: the Cardiovascular Health Study (CHS). J Cardiovasc Electrophysiol (2008) 1.14

Cystatin C and sudden cardiac death risk in the elderly. Circ Cardiovasc Qual Outcomes (2010) 1.14

Circulating and dietary omega-3 and omega-6 polyunsaturated fatty acids and incidence of CVD in the Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc (2013) 1.14

Association of serum phosphate levels with aortic valve sclerosis and annular calcification: the cardiovascular health study. J Am Coll Cardiol (2011) 1.14

Associations of total and high-molecular-weight adiponectin with all-cause and cardiovascular mortality in older persons: the Cardiovascular Health Study. Circulation (2012) 1.14

C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65 years and older. Cancer Causes Control (2009) 1.13

Mineral metabolism markers and the long-term risk of hip fracture: the cardiovascular health study. J Clin Endocrinol Metab (2011) 1.12

Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) and risk of cardiovascular disease in older adults: results from the Cardiovascular Health Study. Atherosclerosis (2009) 1.11

Hemostatic and inflammatory risk factors for intracerebral hemorrhage in a pooled cohort. Stroke (2008) 1.09

Longitudinal changes in adiponectin and inflammatory markers and relation to survival in the oldest old: the Cardiovascular Health Study All Stars study. J Gerontol A Biol Sci Med Sci (2011) 1.09

PROC, PROCR and PROS1 polymorphisms, plasma anticoagulant phenotypes, and risk of cardiovascular disease and mortality in older adults: the Cardiovascular Health Study. J Thromb Haemost (2008) 1.08

Metabolic syndrome, inflammation, and incident heart failure in the elderly: the cardiovascular health study. Circ Heart Fail (2008) 1.08

Autonomic nervous system dysfunction and inflammation contribute to the increased cardiovascular mortality risk associated with depression. Psychosom Med (2010) 1.07

High-density lipoprotein cholesterol and venous thromboembolism in the Longitudinal Investigation of Thromboembolism Etiology (LITE). Blood (2008) 1.07

Fetuin-A, type 2 diabetes, and risk of cardiovascular disease in older adults: the cardiovascular health study. Diabetes Care (2012) 1.06

Mortality in pharmacologically treated older adults with diabetes: the Cardiovascular Health Study, 1989-2001. PLoS Med (2006) 1.06

Fatty acids in the de novo lipogenesis pathway and risk of coronary heart disease: the Cardiovascular Health Study. Am J Clin Nutr (2011) 1.06

The impact of height on the risk of atrial fibrillation: the Cardiovascular Health Study. Eur Heart J (2012) 1.05

Chronic kidney disease, insulin resistance, and incident diabetes in older adults. Clin J Am Soc Nephrol (2012) 1.05

Frequency and type of seafood consumed influence plasma (n-3) fatty acid concentrations. J Nutr (2008) 1.04

Change in circulating adiponectin in advanced old age: determinants and impact on physical function and mortality. The Cardiovascular Health Study All Stars Study. J Gerontol A Biol Sci Med Sci (2010) 1.04

Current employment status, occupational category, occupational hazard exposure and job stress in relation to telomere length: the Multiethnic Study of Atherosclerosis (MESA). Occup Environ Med (2013) 1.04

The relation between C reactive protein and age related macular degeneration in the Cardiovascular Health Study. Br J Ophthalmol (2005) 1.03

Relationship between brachial flow-mediated dilation and carotid intima-media thickness in an elderly cohort: the Cardiovascular Health Study. Atherosclerosis (2007) 1.03

Total and high-molecular-weight adiponectin and risk of incident diabetes in older people. Diabetes Care (2011) 1.01

Comparison of different metabolic syndrome definitions and risks of incident cardiovascular events in the elderly. Metabolism (2011) 1.01

Biomarkers of dairy fatty acids and risk of cardiovascular disease in the Multi-ethnic Study of Atherosclerosis. J Am Heart Assoc (2013) 1.01

Inflammation and stress-related candidate genes, plasma interleukin-6 levels, and longevity in older adults. Exp Gerontol (2009) 1.00

Relations of plasma total and high-molecular-weight adiponectin to new-onset heart failure in adults ≥65 years of age (from the Cardiovascular Health study). Am J Cardiol (2013) 0.99

Neurohormonal and inflammatory hyper-responsiveness to acute mental stress in depression. Biol Psychol (2010) 0.99

Decline in circulating insulin-like growth factors and mortality in older adults: cardiovascular health study all-stars study. J Clin Endocrinol Metab (2012) 0.99

Peak thrombin generation and subsequent venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE) study. J Thromb Haemost (2009) 0.99

Total and high-molecular-weight adiponectin and risk of coronary heart disease and ischemic stroke in older adults. J Clin Endocrinol Metab (2012) 0.98

High insulinlike growth factor binding protein 1 level predicts incident congestive heart failure in the elderly. Am Heart J (2008) 0.97

Articles by these authors

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med (1997) 18.85

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation (2000) 7.37

Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med (1999) 6.92

Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60

Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol (2000) 5.59

Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc (1999) 4.84

Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem (1997) 4.77

Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. Am J Epidemiol (2000) 4.16

Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet (1999) 4.07

Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. Am J Epidemiol (1996) 3.82

The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81

Diabetes in older adults: comparison of 1997 American Diabetes Association classification of diabetes mellitus with 1985 WHO classification. Lancet (1998) 3.61

The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord (2001) 3.39

Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation (1998) 2.83

Association between physical activity and markers of inflammation in a healthy elderly population. Am J Epidemiol (2001) 2.68

The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes (2001) 2.47

Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study. Atherosclerosis (2001) 2.40

Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst (1999) 2.40

Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem (1999) 2.35

Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. Circulation (1999) 2.31

Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum (1999) 2.21

Inflammation in cardiovascular disease: cart, horse, or both? Circulation (1998) 2.18

Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol (1999) 2.15

Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol (1997) 1.90

Lipoprotein lipids in older people. Results from the Cardiovascular Health Study. The CHS Collaborative Research Group. Circulation (1992) 1.79

Epidemiology of low cholesterol levels in older adults. The Cardiovascular Health Study. Circulation (1993) 1.75

Analytical and biologic variability in measures of hemostasis, fibrinolysis, and inflammation: assessment and implications for epidemiology. Am J Epidemiol (1999) 1.73

Prevalence of cardiovascular diseases among older adults. The Cardiovascular Health Study. Am J Epidemiol (1993) 1.63

Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study. Kidney Int (2000) 1.62

T helper-cell phenotype regulates atherosclerosis in mice under conditions of mild hypercholesterolemia. Circulation (2001) 1.57

Intravenous nitroglycerin-induced heparin resistance: a qualitative antithrombin III abnormality. Am Heart J (1990) 1.55

Genome scan of venous thrombosis in a pedigree with protein C deficiency. J Thromb Haemost (2004) 1.49

Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI IIIB Trial) Am J Cardiol (1996) 1.46

Intracerebral hemorrhage related to cerebral amyloid angiopathy and t-PA treatment. Ann Neurol (1991) 1.46

Validity of enzyme-linked immunosorbent assays of cross-linked fibrin degradation products as a measure of clot lysis. Circulation (1990) 1.45

First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS Trial. J Thromb Haemost (2005) 1.42

Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS). Arterioscler Thromb Vasc Biol (1999) 1.37

Black-white differences in subclinical cardiovascular disease among older adults: the Cardiovascular Health Study. CHS Collaborative Research Group. J Clin Epidemiol (1995) 1.34

Fat distribution and hemostatic measures in obese children. Am J Clin Nutr (1998) 1.31

The reliability of medication inventory methods compared to serum levels of cardiovascular drugs in the elderly. J Clin Epidemiol (1999) 1.31

Diabetes mellitus and echocardiographic left ventricular function in free-living elderly men and women: The Cardiovascular Health Study. Am Heart J (1997) 1.29

"Clotspeed," a mathematical simulation of the functional properties of prothrombinase. J Biol Chem (1984) 1.28

Systematically missing confounders in individual participant data meta-analysis of observational cohort studies. Stat Med (2009) 1.27

Longitudinal stability of coagulation, fibrinolysis, and inflammation factors in stored plasma samples. Thromb Haemost (2001) 1.27

Treatment of radial neuropathy associated with fractures of the humerus. J Bone Joint Surg Am (1981) 1.25

Soft tissue sarcomas of the extremities: survival and patterns of failure with conservative surgery and postoperative irradiation compared to surgery alone. Cancer (1982) 1.24

Fibrinogen and factor VIII, but not factor VII, are associated with measures of subclinical cardiovascular disease in the elderly. Results from The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol (1995) 1.24

Sex- and race-related differences in liver-associated serum chemistry tests in young adults in the CARDIA study. Clin Chem (1992) 1.23

Sonographic evaluation of carotid artery atherosclerosis in the elderly: relationship of disease severity to stroke and transient ischemic attack. Radiology (1993) 1.23

Chlamydia pneumoniae, herpes simplex virus type 1, and cytomegalovirus and incident myocardial infarction and coronary heart disease death in older adults : the Cardiovascular Health Study. Circulation (2000) 1.22

Tamoxifen and cardiac risk factors in healthy women: Suggestion of an anti-inflammatory effect. Arterioscler Thromb Vasc Biol (2001) 1.21

Two-dimensional gel electrophoresis of serum specimens from a normal population. Clin Chem (1982) 1.21

Association of C-reactive protein with markers of prevalent atherosclerotic disease. Am J Cardiol (2001) 1.20

Respiratory muscle strength and the risk of incident cardiovascular events. Thorax (2004) 1.20

The prospective association between adiponectin and coronary artery disease among individuals with type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia (2004) 1.18

Desmoid tumors: local control and patterns of relapse following radiation therapy. Int J Radiat Oncol Biol Phys (1983) 1.17

Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I trial. Circulation (1996) 1.16

Plasma fibrinogen: levels and correlates in young adults. The Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Epidemiol (1993) 1.16

Association between patterns of nucleotide variation across the three fibrinogen genes and plasma fibrinogen levels: the Coronary Artery Risk Development in Young Adults (CARDIA) study. J Thromb Haemost (2006) 1.15

Physical activity and physiological cardiac remodelling in a community setting: the Multi-Ethnic Study of Atherosclerosis (MESA). Heart (2009) 1.13

The relation between serum albumin levels and risk of coronary heart disease in the Multiple Risk Factor Intervention Trial. Am J Epidemiol (1991) 1.12

Thrombin generation, inhibition and clinical outcomes in patients with acute myocardial infarction treated with thrombolytic therapy and heparin: results from the GUSTO-I Trial. GUSTO-I Hemostasis Substudy Group. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. J Am Coll Cardiol (1998) 1.10

Plasma fibrinogen as a predictor of total and cause-specific mortality in elderly Japanese-American men. Arterioscler Thromb Vasc Biol (2001) 1.08

The preoperative bleeding time test lacks clinical benefit: College of American Pathologists' and American Society of Clinical Pathologists' position article. Arch Surg (1998) 1.07

Human platelets contain and secrete osteonectin, a major protein of mineralized bone. Proc Natl Acad Sci U S A (1986) 1.07

Computed tomography of musculoskeletal disorders. AJR Am J Roentgenol (1978) 1.07

The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial. J Clin Endocrinol Metab (2000) 1.06

Inherited predisposition to thrombosis. Cell (1993) 1.05

Hormone replacement therapy, inflammation, and hemostasis in elderly women. Arterioscler Thromb Vasc Biol (1999) 1.04

Is visceral adiposity the "enemy within"? Arterioscler Thromb Vasc Biol (2001) 1.04

Soluble intracellular adhesion molecule-1 is associated with cardiovascular disease risk and mortality in older adults. J Thromb Haemost (2006) 1.03

Severe acquired protein C deficiency in purpura fulminans associated with disseminated intravascular coagulation: treatment with protein C concentrate. Pediatrics (1993) 1.02

Treatment of intracapsular hip fractures by the Deyerle method. A comparative review of one hundred and nineteen cases. J Bone Joint Surg Am (1975) 1.02

Plasma lipoproteins support prothrombinase and other procoagulant enzymatic complexes. Arterioscler Thromb Vasc Biol (1998) 1.02

Summary of the scientific conference on dietary fatty acids and cardiovascular health: conference summary from the nutrition committee of the American Heart Association. Circulation (2001) 1.02

Heritability of plasma concentrations of clotting factors and measures of a prethrombotic state in a protein C-deficient family. J Thromb Haemost (2004) 1.01

Stripping membranes at term: can it safely reduce the incidence of post-term pregnancies? Obstet Gynecol (1990) 1.01

Sudden cardiac death, genes, and arrhythmogenesis : consideration of new population and mechanistic approaches from a national heart, lung, and blood institute workshop, part I. Circulation (2001) 1.01

Serum levels of C-reactive protein are associated with obesity, weight gain, and hormone replacement therapy in healthy postmenopausal women. Am J Epidemiol (2001) 1.00

Relationship of plasmin generation to cardiovascular disease risk factors in elderly men and women. Arterioscler Thromb Vasc Biol (1999) 1.00

Association of fibrinogen and coagulation factors VII and VIII with cardiovascular risk factors in the elderly: the Cardiovascular Health Study. Cardiovascular Health Study Investigators. Am J Epidemiol (1996) 1.00

The association of vitamin K status with warfarin sensitivity at the onset of treatment. Br J Haematol (2001) 1.00

TNK-tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trial. Circulation (1997) 0.99

The distribution of coagulation factors VII and VIII and fibrinogen in adults over 65 years. Results from the Cardiovascular Health Study. Ann Epidemiol (1992) 0.99

The prognostic value of serum albumin in healthy older persons with low and high serum interleukin-6 (IL-6) levels. J Am Geriatr Soc (2000) 0.98

Asthma and its association with cardiovascular disease in the elderly. The Cardiovascular Health Study Research Group. J Asthma (1996) 0.98

C-reactive protein is more strongly related to post-glucose load glucose than to fasting glucose in non-diabetic subjects; the Insulin Resistance Atherosclerosis Study. Diabet Med (2002) 0.97

Computed tomography. Its use in space-occupying lesions of the musculoskeletal system. J Bone Joint Surg Am (1978) 0.97

Sample preparation for plasma measurement of plasminogen activator inhibitor-1 antigen in large population studies. Arch Pathol Lab Med (1993) 0.96

Superwarfarin ingestion and detection. Am J Hematol (1991) 0.96

Platelet activation in patients after an acute coronary syndrome: results from the TIMI-12 trial. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol (1999) 0.96

Growth on type I collagen promotes expression of the osteoblastic phenotype in human osteosarcoma MG-63 cells. J Cell Physiol (1992) 0.95

Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes. Circulation (1995) 0.95

Longitudinal assessment of fibrinogen in relation to subclinical cardiovascular disease: the CARDIA study. J Thromb Haemost (2009) 0.94